EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PIEZO1 is essential for the survival and proliferation of acute myeloid leukemia cells

Delphine Lebon iD, Louison Collet, Stefan Djordjevic, Cathy Gomila, Hakim Ouled-Haddou, Jessica Platon, Yohann Demont, Jean-Pierre Marolleau, Alexis Caulier, Loïc Garçon

Cancer Medicine · 2024

DOI: 10.1002/cam4.6984 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Delphine Lebon und 9 weiteren Autor:innen. Beteiligte Einrichtung: HEMATIM UR4666, Université Picardie Jules Verne, Amiens, France. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ligue Contre le Cancer, JNCL.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Leukemogenesis is a complex process that interconnects tumoral cells with their microenvironment, but the effect of mechanosensing in acute myeloid leukemia (AML) blasts is poorly known. PIEZO1 perceives and transmits the constraints of the environment to human cells by acting as a non‐selective calcium channel, but very little is known about its role in leukemogenesis.

Results

For the first time, we show that PIEZO1 is preferentially expressed in healthy hematopoietic stem and progenitor cells in human hematopoiesis, and globally overexpressed in AML cells. In AML subtypes, PIEZO1 expression associates with favorable outcomes as better overall (OS) and disease‐free survival (DFS). If PIEZO1 is expressed and functional in THP1 leukemic myeloid cell line, its chemical activation doesn’t impact the proliferation, differentiation, nor survival of cells. However, the downregulation of PIEZO1 expression dramatically reduces the proliferation and the survival of THP1 cells. We show that PIEZO1 knock‐down blocks the cell cycle in G0/G1 phases of AML cells, impairs the DNA damage response pathways, and critically increases cell death by triggering extrinsic apoptosis pathways.

Conclusions

Altogether, our results reveal a new role for PIEZO1 mechanosensing in the survival and proliferation of leukemic blasts, which could pave the way for new therapeutic strategies to target AML cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteHumansHematopoietic Stem CellsCell DifferentiationHematopoiesisCell DivisionCell ProliferationCell Line, TumorTumor MicroenvironmentIon Channels

Stichwörter der Autor:innen

PIEZO1acute myeloid leukemiaapoptosiscell cycleproliferationsurvival

Substanzen

PIEZO1 protein, humanIon Channels

Autor:innen und Institutionen

  • HEMATIM UR4666, Université Picardie Jules Verne, Amiens, France.
  • Hématologie Clinique et Thérapie Cellulaire, CHU Amiens-Picardie, Amiens, France.
  • Service d'Hématologie Biologie, CHU Amiens-Picardie, Amiens, France.
  • Division of Hematology/Oncology Boston Children's Hospital, Boston, Massachusetts, USA.
  • Department of Medical and Population Genetics, The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.

ORCID-Profile: Delphine Lebon

Förderung

  • Ligue Contre le Cancer
  • JNCL

Zitieren

APA

Lebon, D., Collet, L., Djordjevic, S., Gomila, C., Ouled-Haddou, H., Platon, J., Demont, Y., Marolleau, J. P., Caulier, A., & Garçon, L. (2024). PIEZO1 is essential for the survival and proliferation of acute myeloid leukemia cells. Cancer Medicine. https://doi.org/10.1002/cam4.6984

Vancouver

Lebon D, Collet L, Djordjevic S, Gomila C, Ouled-Haddou H, Platon J, et al. PIEZO1 is essential for the survival and proliferation of acute myeloid leukemia cells. Cancer Medicine. 2024. doi:10.1002/cam4.6984

BibTeX
@article{Lebon2024,
  author = {Lebon, Delphine and Collet, Louison and Djordjevic, Stefan and Gomila, Cathy and Ouled-Haddou, Hakim and Platon, Jessica and Demont, Yohann and Marolleau, Jean-Pierre and Caulier, Alexis and Garçon, Loïc},
  title = {PIEZO1 is essential for the survival and proliferation of acute myeloid leukemia cells},
  journal = {Cancer Medicine},
  year = {2024},
  doi = {10.1002/cam4.6984}
}
Kostenlos starten →